10/13/2025Huadao Secures Over CNY 100M in Series D+2 Financing to Advance CAR-T ...

10/13/2025Lepu Reports Early Clinical Data for ADC Programs in Various Cancers

10/13/2025Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093

10/13/2025Lundbeck's Epilepsy Drug Bexicaserin Granted Breakthrough Therapy Stat...

10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...

10/13/2025CDE Seeks Input on Draft Technical Requirements for Sodium Iodide [131...

10/13/2025CDE Solicits Comments on Draft Guidelines for Bioequivalence Risk Asse...

10/13/2025CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...

10/13/2025China Introduces New Regulations to Govern Clinical Research and Appli...

10/13/2025AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...

10/13/2025Huadao Bio Secures Over CNY 100M in Series D+2 Financing

10/13/2025Kelun-Biotech Presents Promising Phase 1 Data for CLDN18.2 ADC SKB315

10/13/2025CF PharmaTech Soars 161% on Hong Kong IPO Debut

10/13/2025Eccogene Files for Hong Kong IPO

10/13/2025Zenas Secures Global Rights to InnoCare's Orelabrutinib and Next-Gen I...

10/13/20254B Technologies' Novel NGF Receptor Inhibitor 4B03-04 Receives FDA IND...

10/13/2025Hope Medicine Reports Positive Global Phase 2 Results for HMI-115

10/13/2025Walgreens Boots Alliance Fully Exits Nanjing Pharma

10/13/2025Expedition Therapeutics Secures USD 165M in Oversubscribed Series A

10/13/2025Chengdu NRT Raises ~CNY 800M in Series D Financing to Advance Radiopha...

10/13/2025Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...

10/13/2025PegBio Signs Exclusive Licensing Term Sheet with UAE's PDC for PB-119

10/13/2025Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...

10/13/2025USB's Zilbrysq Wins Chinese Approval

10/13/2025CSPC's Novel siRNA Therapy Gains U.S. Green Light for Clinical Trials

10/8/2025Only Two Novel Drugs Win China Approval in September as Local Innovati...

10/8/2025License-Out Deals in China Drop Sharply in September Amid Steady Deal ...

10/8/2025China Biopharma Financing Rebounds in September as IPO Pipeline Surges

10/3/2025GRIT Biotech Raises CNY 380M in Series C Round

10/3/2025TJ Biopharma Secures CNY 600M to Advance Late-Stage Cancer and Rare D...

Page:1/59 Total number of articles:1755: [First][<<] [1] [2] [3] [4] [5] [>>] [End]